Physician profile
David W Janeway
NPI 1821177437
$3,980.06
in general payments reported to CMS, 2019-2025
48 companies · $655 in 2025
The $655 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $319 · 2021: $575 · 2022: $740 · 2023: $548 · 2024: $477 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $734.95 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $317.83 | 2019-2025 | Wegovy, Saxenda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.48 | 2019-2025 | Jardiance |
| Abbvie INC. | $309.33 | 2019-2024 | |
| Lilly USA, LLC | $287.53 | 2019-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $174.35 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $152.64 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $147.62 | 2020-2025 | |
| Boston Scientific Corporation | $108.83 | 2019-2025 | Watchman, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $105.06 | 2022-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $84.93 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $83.26 | 2019-2024 | |
| Biohaven Pharmaceuticals, INC. | $83.11 | 2021 | |
| Amgen INC. | $74.08 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $65.31 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Janeway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.